• About us
    • About ImaBiotech
    • Our team
    • Quality Engagement
    • Careers
    • Contact Imabiotech
  • Innovative platforms
    • Overview of Technologies
    • Mass Spectrometry Imaging
    • Laser Microdissection
    • Multimaging™ Software
    • Spatially Resolved Gene Expression
    • High Multiplexing Proteins & Cell Markers
    • Testing Panels
  • Therapeutic areas
    • Oncology
    • Dermatology
    • Ophthalmology
    • Respiratory diseases
    • Central Nervous System
    • Metabolic Disorders
  • Services
    • Overview of Services
    • Biodistribution
    • Biomarkers Discovery
    • Formulation Screening
    • Digital Pathology Services
    • Drug Delivery
    • PK/PD-Pharmacology
    • Safety support
    • Translational Research
    • Clinical Drug Efficacy
  • Resources
    • Conferences and Webinars
    • Articles and research
    • Press releases & In the Press
    • Imabiotech news

Category: Oncology

oncology-resources

  • European-Mass-spectrometry-Imaging-Conference

    EMSC 2018

  • MALDI-Innovations-Pharma

    MS Imaging Applications in Pharma & Chemical Biology

  • Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways

  • Immuno-oncology-mass-spectrometry-imaging-webinar

    An Application to Immuno-Oncology: our first webinar from our new lab in Boston

  • IDH-Mass-spectrometry-imaging-brain analyze

    Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways

« Previous 1 2 3 4 Next »

Search news




© ImaBiotech 2018-2022

Build Your Pathway